Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-19-058834

Executive VP, Drug Development sold 24,000 shares at $26.00 ($624,000)

  • Executive VP, Drug Development acquired 24,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

MANHARD KIMBERLY · Executive VP, Drug Development

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-11-29 Exercise or conversion : show line 1 in the form +24,000 $13.00 $312,000 24,000 D
2019-11-29 Sale : show line 2 in the form −24,000 $26.00 $624,000 0 D
Open-market sales · 24,000 sh · avg $26.00 · $624,000

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2019-11-29 Exercise or conversion : show line 3 in the form Employee Stock Option (Right to Buy) −24,000 $13.00 2026-12-21 24,000 58,416 D
Loading xslF345X03/doc4.xml…